Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Skinbiotherap. (SBTX) Share Price

Price 6.25p on 20-03-2026 at 18:50:08
Change -3.35p -34.9%
Buy 6.50p
Sell 6.00p
Last Trade: Sell 12,500.00 at 6.005p
Day's Volume: 5,723,190
Last Close: 6.25p
Open: 9.55p
ISIN: GB00BF33H870
Day's Range 5.50p - 9.55p
52wk Range: 5.20p - 27.50p
Market Capitalisation: £16.20m
VWAP: 6.448146p
Shares in Issue: 259.17m

Skinbiotherap. (SBTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 12,500 6.005p Ordinary
16:29:48 - 20-Mar-26
Buy* 10 6.4995p Ordinary
16:27:16 - 20-Mar-26
Buy* 230 6.4995p Ordinary
16:26:29 - 20-Mar-26
Buy* 21,703 6.28p Ordinary
16:25:50 - 20-Mar-26
Buy* 15,923 6.28p Ordinary
16:24:42 - 20-Mar-26
Sell* 24,193 6.20p Ordinary
16:24:21 - 20-Mar-26
Sell* 7,500 6.20p Ordinary
16:24:20 - 20-Mar-26
Sell* 5,000 6.20p Ordinary
16:23:28 - 20-Mar-26
Buy* 7,961 6.28p Ordinary
16:21:48 - 20-Mar-26
Buy* 1,029 6.315p Ordinary
16:18:52 - 20-Mar-26
See more Skinbiotherap. trades

Skinbiotherap. (SBTX) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Mar 2026 (Fri) 9.55 9.55 5.50 6.25 5,723,190
19th Mar 2026 (Thu) 9.60 9.60 9.60 9.60 109,141
18th Mar 2026 (Wed) 10.50 10.50 9.60 9.60 631,104
17th Mar 2026 (Tue) 10.50 10.50 10.50 10.50 286,020
16th Mar 2026 (Mon) 10.50 10.50 10.50 10.50 330,738
13th Mar 2026 (Fri) 10.00 11.00 10.00 10.50 1,124,363
12th Mar 2026 (Thu) 10.75 10.75 9.75 10.00 1,647,979
11th Mar 2026 (Wed) 12.00 12.00 10.75 10.75 648,148
10th Mar 2026 (Tue) 11.75 12.25 11.75 12.00 500,437
9th Mar 2026 (Mon) 12.50 13.00 11.75 11.75 3,287,742
6th Mar 2026 (Fri) 10.50 13.25 11.75 12.50 7,622,031
5th Mar 2026 (Thu) 9.50 10.75 9.50 10.75 1,766,306
4th Mar 2026 (Wed) 9.50 9.56 9.56 9.56 1,139,108
3rd Mar 2026 (Tue) 9.25 9.80 9.25 9.50 5,860,338
2nd Mar 2026 (Mon) 8.00 9.32 9.32 9.32 4,121,416
27th Feb 2026 (Fri) 7.75 8.00 8.00 8.00 2,901,529
26th Feb 2026 (Thu) 7.25 8.00 7.75 7.75 8,368,464
25th Feb 2026 (Wed) 6.25 7.75 6.25 7.25 12,411,853
24th Feb 2026 (Tue) 5.25 6.25 5.25 6.25 5,649,235
23rd Feb 2026 (Mon) 5.25 5.25 5.25 5.25 2,631,819
See more Skinbiotherap. price history

Skinbiotherap. (SBTX) Regulatory News

Date Source Headline
20th Mar 2026 11:30 am RNS Update On Board Investigation and Interims Date
13th Mar 2026 7:00 am RNS Holding(s) in Company
13th Mar 2026 7:00 am RNS Holding(s) in Company
9th Mar 2026 7:00 am RNS Appointment of the Interim CEO to the Board
2nd Mar 2026 7:00 am RNS Appointment of Interim CEO
20th Feb 2026 7:00 am RNS Independent Investigation Appointment
16th Feb 2026 7:00 am RNS Update on Board Investigation
13th Feb 2026 7:00 am RNS Resignation of CEO
12th Feb 2026 11:00 am RNS Holding(s) in Company
11th Feb 2026 7:00 am RNS Issue of Equity and Total Voting Rights
See more Skinbiotherap. regulatory news

Skinbiotherap. (SBTX) Share News

SkinBioTherapeutics faces April trading suspension until review ends

20th Mar 2026 14:26

(Alliance News) - SkinBioTherapeutics PLC shares slid on Friday after the firm said it will be suspended from trading on the AIM market at the start of April until the review of its former chief executive's conduct concludes. Read More

SkinBioTherapeutics adds interim CEO Rachel Parsonage to board

9th Mar 2026 14:35

(Alliance News) - SkinBioTherapeutics on Monday confirmed the appointment of Interim Chief Executive Officer Rachel Parsonage to its board after completing regulatory due diligence. Read More

SkinBioTherapeutics appoints interim CEO as investigation continues

2nd Mar 2026 16:27

(Alliance News) - SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve out a way forward from the suspension and resignation of its past CEO. Read More

LONDON MARKET CLOSE: FTSE 100 climbs on strong retail sales data

20th Feb 2026 16:56

(Alliance News) - Stock prices in London closed higher on Friday, as a swathe of domestic economic data was well-received and the US Supreme Court ruled President Donald Trump's tariff programme is illegal. Read More

IN BRIEF: SkinBioTherapeutics board member to oversee external probe

20th Feb 2026 13:30

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investigation of the events that led to the departure of Stuart Ashman as chief executive officer. Levett, who chairs the board's audit committee, will work with FRP Advisory, which the board has engaged to undertake a "forensic review". Read More

See more Skinbiotherap. news
FTSE 100 Latest
Value9,918.33
Change-145.17

Login to your account

Forgot Password?

Not Registered